A 10-Amino-Acid Peptide Gel That Delivers Cancer Drugs Directly to Tumors
A short peptide made of just 10 amino acids forms an injectable hydrogel that delivers the chemotherapy drug paclitaxel directly to tumors and releases it slowly in response to the tumor's acidic environment.
Quick Facts
What This Study Found
The short peptide KK (sequence: KIKIDPPIKIK) has an angular structure created by its proline-proline core that enables it to form a network hydrogel under neutral pH, trapping hydrophobic paclitaxel. Under the slightly acidic conditions found in tumors, the gel structure changes and releases the drug in a sustained manner.
In vitro and in vivo experiments demonstrated that the drug-loaded hydrogel improved anti-tumor efficacy while showing good biocompatibility and biological safety. The peptide's functional properties are achieved with only 10 amino acids, making it cheaper and easier to synthesize than longer peptide-based delivery systems.
Key Numbers
How They Did This
The peptide was synthesized using solid-phase peptide synthesis. Its structure was examined under neutral and acidic conditions using transmission electron microscopy and circular dichroism. Drug release was measured in vitro. Injectability was confirmed through rheological testing. Anti-tumor efficacy was tested in cell culture (in vitro cytotoxicity) and in tumor-bearing mice (in vivo). Biocompatibility was assessed both in cells and in animals.
Why This Research Matters
Many powerful chemotherapy drugs like paclitaxel are limited by poor solubility and harsh side effects when given systemically. Peptide hydrogels that respond to tumor acidity could deliver drugs locally with sustained release, reducing side effects while maintaining or improving efficacy. The fact that this works with just 10 amino acids makes it potentially practical and affordable to manufacture.
The Bigger Picture
Self-assembling peptide hydrogels are an active area of drug delivery research. This study contributes a minimalist design — achieving tumor-responsive drug release with one of the shortest peptide sequences reported. As the field moves toward clinical translation, simpler, cheaper peptide carriers like this could make targeted drug delivery more accessible.
What This Study Doesn't Tell Us
The study was conducted in cell lines and mice, not humans. The abstract does not report specific tumor reduction percentages or survival data. Long-term stability of the hydrogel in vivo and its performance with drugs other than paclitaxel were not addressed.
Questions This Raises
- ?Could this peptide hydrogel system deliver other hydrophobic drugs beyond paclitaxel for different cancer types?
- ?How does the drug release rate compare to other peptide-based and polymer-based hydrogel delivery systems?
- ?What would be needed to advance this from mouse studies to human clinical trials?
Trust & Context
- Key Stat:
- Just 10 amino acids One of the shortest peptide sequences shown to form a functional, pH-responsive drug delivery hydrogel for cancer treatment
- Evidence Grade:
- This is a preclinical study with in vitro and in vivo (mouse) data. It demonstrates proof of concept for the delivery system but has not been tested in humans.
- Study Age:
- Published in 2025, this represents current research in peptide-based drug delivery and self-assembling biomaterials.
- Original Title:
- Short peptide hydrogel with angular structure for hydrophobic antitumor drug delivery and controlled release.
- Published In:
- Colloids and surfaces. B, Biointerfaces, 254, 114793 (2025)
- Authors:
- Yao, Qingqing, Gao, Jie(2), Liu, Linsheng, Shi, Jinfang, Zafar, Hajra, Khan, Muhammad Ijaz, Zhu, Jianguo, Raza, Faisal, Zhu, Ying
- Database ID:
- RPEP-14354
Evidence Hierarchy
Frequently Asked Questions
How does the peptide gel know to release the drug at the tumor?
Tumors create a slightly acidic environment compared to healthy tissue. The peptide hydrogel is stable at normal body pH but its structure changes in acidic conditions, causing it to gradually release the trapped paclitaxel right at the tumor site.
Why is a 10-amino-acid peptide significant for drug delivery?
Shorter peptides are cheaper and easier to manufacture than longer ones. Achieving effective drug delivery with just 10 amino acids means this approach could be more practical and affordable to scale up for clinical use compared to complex protein-based delivery systems.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-14354APA
Yao, Qingqing; Gao, Jie; Liu, Linsheng; Shi, Jinfang; Zafar, Hajra; Khan, Muhammad Ijaz; Zhu, Jianguo; Raza, Faisal; Zhu, Ying. (2025). Short peptide hydrogel with angular structure for hydrophobic antitumor drug delivery and controlled release.. Colloids and surfaces. B, Biointerfaces, 254, 114793. https://doi.org/10.1016/j.colsurfb.2025.114793
MLA
Yao, Qingqing, et al. "Short peptide hydrogel with angular structure for hydrophobic antitumor drug delivery and controlled release.." Colloids and surfaces. B, 2025. https://doi.org/10.1016/j.colsurfb.2025.114793
RethinkPeptides
RethinkPeptides Research Database. "Short peptide hydrogel with angular structure for hydrophobi..." RPEP-14354. Retrieved from https://rethinkpeptides.com/research/yao-2025-short-peptide-hydrogel-with
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.